Ying Shen

机构：Hebei Medical University, Fourth Hospital of Hebei Medical University, Beijing Center for Disease Prevention and Control, Vrije Universiteit Amsterdam · ORCID：0000-0003-0656-7377

发表论文 197 篇 · 总被引 3634 次 · h-index 35

代表论文

• Combining Network Pharmacology, Molecular Docking and Experimental Validation to Explore the Effects and Mechanisms of Indirubin on Acute Lymphoblastic Leukemia (2025 · Drug Design Development and Therapy · 被引 12)
• Emerging roles of small extracellular vesicles in metabolic reprogramming and drug resistance in cancers (2024 · Cancer Drug Resistance · 被引 11)
• Elevated systemic immune-inflammatory index predicts poor coronary collateralization in type 2 diabetic patients with chronic total occlusion (2024 · Frontiers in Cardiovascular Medicine · 被引 10)
• The Role of SLC7A11 in Tumor Progression and the Regulation Mechanisms Involved in Ferroptosis (2025 · Cancer Management and Research · 被引 9)
• YY1 downregulation underlies therapeutic response to molecular targeted agents (2024 · Cell Death and Disease · 被引 9)
• A phosphoglycerate mutase 1 allosteric inhibitor restrains TAM-mediated colon cancer progression (2024 · Acta Pharmaceutica Sinica B · 被引 9)